Navigation Links
Telik Announces Financial Results for 2008 Third Quarter
Date:11/5/2008

PALO ALTO, Calif., Nov. 5 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) reported a net loss of $8.0 million, or $0.15 per share, for the third quarter ended September 30, 2008, compared with a net loss of $11.6 million, or $0.22 per share, for the comparable period in 2007. The $8.0 million net loss includes a $670,000 impairment charge related to corporate and municipal notes investments with an auction reset feature, or auction rate securities, which is reflected in interest and other income (expense). As of September 30, 2008, Telik has recognized impairment charges totaling $6.2 million against $18.7 million of par value auction rate securities. At September 30, 2008, Telik had $64.6 million in cash, cash equivalents and investments including restricted investments, compared to $72.4 million at June 30, 2008 and $93.2 million at December 31, 2007.

All of Telik's auction rate securities were sold to the Company by UBS AG ("UBS"). In October 2008, UBS offered Telik the right to sell at par value all of its auction-rate securities to UBS during a two-year period beginning June 30, 2010. The offer to accept this right is non-transferable and expires on November 14, 2008.

For the quarter ended September 30, 2008, total operating costs and expenses were $7.8 million, compared with $13.0 million in the 2007 third quarter and $11.0 million in the second quarter of 2008. Operating expenses in the 2008 third quarter included stock-based compensation expense of approximately $1.6 million. Operating expenses were approximately 40% lower in the third quarter of 2008 compared with the same period in 2007, primarily as a result of reduced clinical trial and related expenses as well as lower headcount and administrative expenses.
'/>"/>

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Telik Announces Top-Line Results From Assist-5 Trial of Telcyta(R) in Combination With Pegylated Liposomal Doxorubicin in Platinum Refractory and Resistant Ovarian Cancer
2. Telik Announces 2008 Third Quarter Financial Release, Conference Call and Webcast
3. Telik Announces Receipt of Nasdaq Notice
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. ReceptorBio Announces Diabetes License Agreement With Telik
6. Telik Announces Financial Results For 2008 Second Quarter
7. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
8. Telik Announces Publication of Diabetes Research in Bioorganic & Medicinal Chemistry Letters
9. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
10. Telik Announces First Quarter 2008 Financial Results
11. Telik Presents Preclinical Data at 99th Annual Meeting of the American Association for Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... HOUSTON (July 29, 2014) Tough, ultralight foam ... and shape through a chemical process invented at Rice ... "GO-0.5BN" looks like a nanoscale building, with floors and ... a pair of two-dimensional materials: floors and walls of ... boron nitride platelets. , The researchers say the ...
(Date:7/29/2014)... 29, 2014 Second generation biofuels are a ... fossil fuels. However, as natural gas is very cheap, this ... are not as valuable as they could be in comparison ... financing projects, has made it difficult for renewable energy developers ... off the ground. For these reasons, certain companies have shifted ...
(Date:7/29/2014)... , July 29, 2014 A ... equipment market (types, applications and geography) - Size, Share, ... Opportunities, Segmentation and Forecast, 2013 - 2020", suggests that ... $12.1 billion by 2020 registering a CAGR of 11.1% ... breakthrough achieved by the electro surgical devices in operative ...
(Date:7/29/2014)... Rockville, MD (PRWEB) July 29, 2014 ... (ITI), a vaccine pioneer in the biotechnology industry, ... firm Newport Coast Securities, Inc. to explore financing ... commercializing LAMP-vax technology, a breakthrough vaccine platform with ... immunotherapy market. The company exclusively licensed the well-established ...
Breaking Biology Technology:Tough foam from tiny sheets 2Renewable Waste Intelligence: Could Renewable Chemicals Be the Future for the Renewable Energy Industry? 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 2Global Surgical Equipment Market is expected to reach $12.1 billion by 2020 - Allied Market Research 3Immunomic Therapeutics Engages Newport Coast Securities, Inc. 2Immunomic Therapeutics Engages Newport Coast Securities, Inc. 3
... Lab to Offer Quantitative Coronary Angiographic ... Analysis ... plc (NASDAQ: ICLR;,ISIN:IE0005711209), a global provider of outsourced development ... that its Medical Imaging division has become the first ...
... and law enforcement officials may some day have a new ... air for virtually all of the major threat agents that ... is under development by a team of Lawrence Livermore National ... in laboratory and field experiments. , In their latest advance, ...
... San Antonio (June 30, 2008) Researchers at The University ... Emerging Infectious Diseases and The University of Texas Health Science ... believed to play a role in controlling the early infectious ... bioterrorism agent that is the cause of tularemia. The findings ...
Cached Biology Technology:ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies 2Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances 2Tests show LLNL detection instrument can monitor the air for all major terrorist threat substances 3UTSA/UTHSCSA publish results on bio-threat agent 2
(Date:7/30/2014)... journal Scientific Reports , published by Nature ... that while global temperature is indeed increasing, so too ... each year,s average hottest and coldest temperatures will likely ... a wider range of potential high and low temperate ... even as overall temperatures rise, we may still continue ...
(Date:7/29/2014)... New research by academics in the University of Bristol,s ... we take liquid calories into account when planning meals. ... for the Study of Ingestive Behavior Conference (SSIB 2014) ... August], argues that we do. , The team was ... the School of Experimental Psychology. , As part of ...
(Date:7/29/2014)... The advanced optical methods and applications for imaging and ... in the neurosciences were the inspiration behind Neurophotonics ... international society for optics and photonics. , The first ... in the United States, and a special section features ... examples of the impact that optics and photonics will ...
Breaking Biology News(10 mins):Big data confirms climate extremes are here to stay 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 2SPIE launches Neurophotonics journal with special section on BRAIN Initiative 3
... University of New Hampshire researchers have received a ... farm as a sustainable closed agroecosystem, exploring viable ... grant, from the U.S. Department of Agriculture,s Sustainable ... explore whether closing energy and nutrient cycles could ...
... surface waters in the arid deserts of the U.S. ... fascinated scientists for over two centuries. A new publication ... diversity of closed basins, ancient lake beds, and partially ... Marith C. Reheis of the USGS, "tantalizes scientists with ...
... magazine dedicated to covering the global environment, is launching ... the former editor of Mother Jones and Audubon magazines, ... leading Web sites for commentary and reporting on the ... inaugural edition features articles by noted environmental advocate and ...
Cached Biology News:UNH receives $380,000 grant to study organic dairy as closed ecosystem 2UNH receives $380,000 grant to study organic dairy as closed ecosystem 3Yale Environment 360 magazine launches online 2
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ...
... pleiotropic cytokine produced by activated T cells, ... the growth of some tumour and normal ... Kaposis sarcoma cell proliferation, cytokine release from ... expression on hepatoma cells. Mouse OSM was ...
... The PHD2000 syringe pump series combines Harvard ... user interface and a wide range of configuration ... contains the dimensions of syringes from all the ... you read all the pertinent information from across ...
Mouse monoclonal [34B12] to Nop5p + Nop58p - Nucleolar Marker ( Abpromise for all tested applications)....
Biology Products: